サマリー

Adapaleneは第三世代のレチノイドで、主に軽度から中等度のニキビの治療に使用されますが、毛孔性角化症やその他の皮膚疾患の治療にも使用されます。

市場分析と洞察。世界のAdapalene市場
Adapaleneの世界市場規模は、2020年のXX百万米ドルから、2021-2027年の間にXX％のCAGRで、2027年にXX百万米ドルに達すると予測されています。
本レポートは、業界標準の正確な分析と高いデータの整合性により、世界のAdapalene市場で得られる主要な機会を明らかにし、プレイヤーが市場での強力なポジションを獲得するのに役立つ見事な試みを行っています。本レポートの購入者は、収益面でのAdapalene世界市場全体のサイズを含む、検証済みの信頼できる市場予測にアクセスすることができます。
本レポートは、Adapaleneの世界市場において競合他社よりも優位に立ち、永続的な成功を収めるための有効なツールであることを証明しています。本レポートに掲載されているすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、世界のAdapalene市場を詳細に調査するために、ユニークで業界最高の調査・分析手法を用いています。

世界のAdapaleneの範囲と市場規模
Adapalene市場は、企業別、地域（国）別、タイプ別、アプリケーション別に分類されています。世界のAdapalene市場に参加するプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント分析では、2016年から2027年までの期間における、タイプ別、アプリケーション別の収益と予測に焦点を当てています。

タイプ別セグメント
クリーム
ジェル
ローション

アプリケーション別
病院
調剤薬局
スキンクリニック
ビューティーセンター
ブリック＆モルタルファーマシー
その他

地域別
北アメリカ
アメリカ
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
北欧
その他のヨーロッパ諸国
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア諸国
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中近東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他の中東・アフリカ地域

会社別
ガルデルマ
グレンマーク・ファーマシューティカルズ
フーゲラ・ファーマシューティカルズ
エーエス・メディケーション・ソリューションズ
タロ・ファーマシューティカルズ
サンドス社
プラスコ・ラボラトリーズ
アクタビス・ファーマ・カンパニー
ペリゴ
フィジシャンズ・トータル・ケア
DPTラボラトリーズ
天津金耀製薬
黒龍江省福和製薬集団
四川明新製薬
海南泉星製薬
江蘇中丹製薬
江蘇富邦製薬

ページTOPに戻る

目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adapalene Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cream
1.2.3 Gel
1.2.4 Lotion
1.3 Market by Application
1.3.1 Global Adapalene Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Compounding Pharmacy
1.3.4 Skin Clinic
1.3.5 Beauty Center
1.3.6 Brick-and-mortar Pharmacy
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Adapalene Market Perspective (2016-2027)
2.2 Adapalene Growth Trends by Regions
2.2.1 Adapalene Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Adapalene Historic Market Share by Regions (2016-2021)
2.2.3 Adapalene Forecasted Market Size by Regions (2022-2027)
2.3 Adapalene Industry Dynamic
2.3.1 Adapalene Market Trends
2.3.2 Adapalene Market Drivers
2.3.3 Adapalene Market Challenges
2.3.4 Adapalene Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Adapalene Players by Revenue
3.1.1 Global Top Adapalene Players by Revenue (2016-2021)
3.1.2 Global Adapalene Revenue Market Share by Players (2016-2021)
3.2 Global Adapalene Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Adapalene Revenue
3.4 Global Adapalene Market Concentration Ratio
3.4.1 Global Adapalene Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adapalene Revenue in 2020
3.5 Adapalene Key Players Head office and Area Served
3.6 Key Players Adapalene Product Solution and Service
3.7 Date of Enter into Adapalene Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Adapalene Breakdown Data by Type
4.1 Global Adapalene Historic Market Size by Type (2016-2021)
4.2 Global Adapalene Forecasted Market Size by Type (2022-2027)

5 Adapalene Breakdown Data by Application
5.1 Global Adapalene Historic Market Size by Application (2016-2021)
5.2 Global Adapalene Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Adapalene Market Size (2016-2027)
6.2 North America Adapalene Market Size by Type
6.2.1 North America Adapalene Market Size by Type (2016-2021)
6.2.2 North America Adapalene Market Size by Type (2022-2027)
6.2.3 North America Adapalene Market Size by Type (2016-2027)
6.3 North America Adapalene Market Size by Application
6.3.1 North America Adapalene Market Size by Application (2016-2021)
6.3.2 North America Adapalene Market Size by Application (2022-2027)
6.3.3 North America Adapalene Market Size by Application (2016-2027)
6.4 North America Adapalene Market Size by Country
6.4.1 North America Adapalene Market Size by Country (2016-2021)
6.4.2 North America Adapalene Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Adapalene Market Size (2016-2027)
7.2 Europe Adapalene Market Size by Type
7.2.1 Europe Adapalene Market Size by Type (2016-2021)
7.2.2 Europe Adapalene Market Size by Type (2022-2027)
7.2.3 Europe Adapalene Market Size by Type (2016-2027)
7.3 Europe Adapalene Market Size by Application
7.3.1 Europe Adapalene Market Size by Application (2016-2021)
7.3.2 Europe Adapalene Market Size by Application (2022-2027)
7.3.3 Europe Adapalene Market Size by Application (2016-2027)
7.4 Europe Adapalene Market Size by Country
7.4.1 Europe Adapalene Market Size by Country (2016-2021)
7.4.2 Europe Adapalene Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Adapalene Market Size (2016-2027)
8.2 Asia-Pacific Adapalene Market Size by Type
8.2.1 Asia-Pacific Adapalene Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Adapalene Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Adapalene Market Size by Type (2016-2027)
8.3 Asia-Pacific Adapalene Market Size by Application
8.3.1 Asia-Pacific Adapalene Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Adapalene Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Adapalene Market Size by Application (2016-2027)
8.4 Asia-Pacific Adapalene Market Size by Region
8.4.1 Asia-Pacific Adapalene Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Adapalene Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Adapalene Market Size (2016-2027)
9.2 Latin America Adapalene Market Size by Type
9.2.1 Latin America Adapalene Market Size by Type (2016-2021)
9.2.2 Latin America Adapalene Market Size by Type (2022-2027)
9.2.3 Latin America Adapalene Market Size by Type (2016-2027)
9.3 Latin America Adapalene Market Size by Application
9.3.1 Latin America Adapalene Market Size by Application (2016-2021)
9.3.2 Latin America Adapalene Market Size by Application (2022-2027)
9.3.3 Latin America Adapalene Market Size by Application (2016-2027)
9.4 Latin America Adapalene Market Size by Country
9.4.1 Latin America Adapalene Market Size by Country (2016-2021)
9.4.2 Latin America Adapalene Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Adapalene Market Size (2016-2027)
10.2 Middle East & Africa Adapalene Market Size by Type
10.2.1 Middle East & Africa Adapalene Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Adapalene Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Adapalene Market Size by Type (2016-2027)
10.3 Middle East & Africa Adapalene Market Size by Application
10.3.1 Middle East & Africa Adapalene Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Adapalene Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Adapalene Market Size by Application (2016-2027)
10.4 Middle East & Africa Adapalene Market Size by Country
10.4.1 Middle East & Africa Adapalene Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Adapalene Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Galderma
11.1.1 Galderma Company Details
11.1.2 Galderma Business Overview
11.1.3 Galderma Adapalene Introduction
11.1.4 Galderma Revenue in Adapalene Business (2016-2021)
11.1.5 Galderma Recent Development
11.2 Glenmark Pharmaceuticals
11.2.1 Glenmark Pharmaceuticals Company Details
11.2.2 Glenmark Pharmaceuticals Business Overview
11.2.3 Glenmark Pharmaceuticals Adapalene Introduction
11.2.4 Glenmark Pharmaceuticals Revenue in Adapalene Business (2016-2021)
11.2.5 Glenmark Pharmaceuticals Recent Development
11.3 Fougera Pharmaceuticals
11.3.1 Fougera Pharmaceuticals Company Details
11.3.2 Fougera Pharmaceuticals Business Overview
11.3.3 Fougera Pharmaceuticals Adapalene Introduction
11.3.4 Fougera Pharmaceuticals Revenue in Adapalene Business (2016-2021)
11.3.5 Fougera Pharmaceuticals Recent Development
11.4 A-S Medication Solutions
11.4.1 A-S Medication Solutions Company Details
11.4.2 A-S Medication Solutions Business Overview
11.4.3 A-S Medication Solutions Adapalene Introduction
11.4.4 A-S Medication Solutions Revenue in Adapalene Business (2016-2021)
11.4.5 A-S Medication Solutions Recent Development
11.5 Taro Pharmaceuticals
11.5.1 Taro Pharmaceuticals Company Details
11.5.2 Taro Pharmaceuticals Business Overview
11.5.3 Taro Pharmaceuticals Adapalene Introduction
11.5.4 Taro Pharmaceuticals Revenue in Adapalene Business (2016-2021)
11.5.5 Taro Pharmaceuticals Recent Development
11.6 Sandoz Inc.
11.6.1 Sandoz Inc. Company Details
11.6.2 Sandoz Inc. Business Overview
11.6.3 Sandoz Inc. Adapalene Introduction
11.6.4 Sandoz Inc. Revenue in Adapalene Business (2016-2021)
11.6.5 Sandoz Inc. Recent Development
11.7 Prasco Laboratories
11.7.1 Prasco Laboratories Company Details
11.7.2 Prasco Laboratories Business Overview
11.7.3 Prasco Laboratories Adapalene Introduction
11.7.4 Prasco Laboratories Revenue in Adapalene Business (2016-2021)
11.7.5 Prasco Laboratories Recent Development
11.8 Actavis Pharma Company
11.8.1 Actavis Pharma Company Company Details
11.8.2 Actavis Pharma Company Business Overview
11.8.3 Actavis Pharma Company Adapalene Introduction
11.8.4 Actavis Pharma Company Revenue in Adapalene Business (2016-2021)
11.8.5 Actavis Pharma Company Recent Development
11.9 Perrigo
11.9.1 Perrigo Company Details
11.9.2 Perrigo Business Overview
11.9.3 Perrigo Adapalene Introduction
11.9.4 Perrigo Revenue in Adapalene Business (2016-2021)
11.9.5 Perrigo Recent Development
11.10 Physicians Total Care
11.10.1 Physicians Total Care Company Details
11.10.2 Physicians Total Care Business Overview
11.10.3 Physicians Total Care Adapalene Introduction
11.10.4 Physicians Total Care Revenue in Adapalene Business (2016-2021)
11.10.5 Physicians Total Care Recent Development
11.11 DPT Laboratories
11.11.1 DPT Laboratories Company Details
11.11.2 DPT Laboratories Business Overview
11.11.3 DPT Laboratories Adapalene Introduction
11.11.4 DPT Laboratories Revenue in Adapalene Business (2016-2021)
11.11.5 DPT Laboratories Recent Development
11.12 Tianjin Jinyao Pharmaceutical
11.12.1 Tianjin Jinyao Pharmaceutical Company Details
11.12.2 Tianjin Jinyao Pharmaceutical Business Overview
11.12.3 Tianjin Jinyao Pharmaceutical Adapalene Introduction
11.12.4 Tianjin Jinyao Pharmaceutical Revenue in Adapalene Business (2016-2021)
11.12.5 Tianjin Jinyao Pharmaceutical Recent Development
11.13 Heilongjiang fuhe Pharmaceutical Group
11.13.1 Heilongjiang fuhe Pharmaceutical Group Company Details
11.13.2 Heilongjiang fuhe Pharmaceutical Group Business Overview
11.13.3 Heilongjiang fuhe Pharmaceutical Group Adapalene Introduction
11.13.4 Heilongjiang fuhe Pharmaceutical Group Revenue in Adapalene Business (2016-2021)
11.13.5 Heilongjiang fuhe Pharmaceutical Group Recent Development
11.14 Sichuan Mingxin Pharmaceutical
11.14.1 Sichuan Mingxin Pharmaceutical Company Details
11.14.2 Sichuan Mingxin Pharmaceutical Business Overview
11.14.3 Sichuan Mingxin Pharmaceutical Adapalene Introduction
11.14.4 Sichuan Mingxin Pharmaceutical Revenue in Adapalene Business (2016-2021)
11.14.5 Sichuan Mingxin Pharmaceutical Recent Development
11.15 Hainan Quanxing Pharmaceutical
11.15.1 Hainan Quanxing Pharmaceutical Company Details
11.15.2 Hainan Quanxing Pharmaceutical Business Overview
11.15.3 Hainan Quanxing Pharmaceutical Adapalene Introduction
11.15.4 Hainan Quanxing Pharmaceutical Revenue in Adapalene Business (2016-2021)
11.15.5 Hainan Quanxing Pharmaceutical Recent Development
11.16 Jiangsu Zhongdan Pharmaceutical
11.16.1 Jiangsu Zhongdan Pharmaceutical Company Details
11.16.2 Jiangsu Zhongdan Pharmaceutical Business Overview
11.16.3 Jiangsu Zhongdan Pharmaceutical Adapalene Introduction
11.16.4 Jiangsu Zhongdan Pharmaceutical Revenue in Adapalene Business (2016-2021)
11.16.5 Jiangsu Zhongdan Pharmaceutical Recent Development
11.17 Jiangsu Fubang Pharmaceutical
11.17.1 Jiangsu Fubang Pharmaceutical Company Details
11.17.2 Jiangsu Fubang Pharmaceutical Business Overview
11.17.3 Jiangsu Fubang Pharmaceutical Adapalene Introduction
11.17.4 Jiangsu Fubang Pharmaceutical Revenue in Adapalene Business (2016-2021)
11.17.5 Jiangsu Fubang Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details